Skip to main content

Table 1 Clinical characteristics of patients on admission to intensive care unit

From: Comparison of albicans vs. non-albicans candidemia in French intensive care units

  Total
N = 136
Candidemia due to C. albicans
N = 78
Candidemia due to non-albicans Candida species
N = 58
P value
Age (years) 62.1 ± 14.9 61.0 ± 17.2 63.5 ± 11.1 0.32
Male gender 84 (61.8) 45 (57.7) 39 (67.2) 0.26
SAPS II 53.8 ± 20.4 57.4 ± 22.8 48.7 ± 15.5 0.015
SOFA 9.6 ± 4.7 10.4 ± 4.7 8.6 ± 4.6 0.03
Underlying disease*     0.35
   Absent or nonfatal 63 (46.3) 37 (47.4) 26 (44.8)  
   Ultimately fatal 58 (42.7) 35 (44.9) 23 (39.7)  
   Rapidly fatal 15 (11.0) 6 (7.7) 9 (15.5)  
Chronic renal failure 26 (19.1) 16 (20.5) 10 (17.2) 0.63
Type 1 diabetes mellitus 16 (11.8) 8 (10.3) 8 (13.8) 0.52
Solid neoplastic tumor 32 (23.5) 19 (24.4) 13 (22.4) 0.79
Hematological malignancy 7 (5.1) 4 (5.1) 3 (5.2) 0.99
Immunosuppression 28 (20.6) 15 (19.2) 13 (22.4) 0.65
   Corticotherapy 10 (7.4) 3 (3.8) 7 (12.1) 0.06
   HIV infection 2 (1.5) 2 (2.6) 0 0.17
   Cancer chemotherapy 10 (7.4) 5 (6.4) 5 (8.6) 0.78
   Organ transplantation 5 (3.7) 2 (2.6) 3 (5.2) 0.50
   Immunosuppressant therapy 4 (2.9) 2 (2.6) 2 (3.4) 0.88
Intravenous drug use 2 (1.5) 1 (1.3) 1 (1.7) 0.83
Neutropenia (<500/mm3) 9 (6.6) 2 (2.6) 7 (12.1) 0.04
  1. Results are expressed as mean ± SD values or numbers (%) of patients.
  2. HIV: human immunodeficiency virus; SAPS: simplified acute physiology score; SOFA: sepsis-related organ failure assessment
  3. *Classified according to the criteria proposed by McCabe and Jackson [17]